JP2012529272A5 - - Google Patents

Download PDF

Info

Publication number
JP2012529272A5
JP2012529272A5 JP2012514307A JP2012514307A JP2012529272A5 JP 2012529272 A5 JP2012529272 A5 JP 2012529272A5 JP 2012514307 A JP2012514307 A JP 2012514307A JP 2012514307 A JP2012514307 A JP 2012514307A JP 2012529272 A5 JP2012529272 A5 JP 2012529272A5
Authority
JP
Japan
Prior art keywords
seq
angiopep
disease
compound according
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012514307A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012529272A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2010/000889 external-priority patent/WO2010142035A1/en
Publication of JP2012529272A publication Critical patent/JP2012529272A/ja
Publication of JP2012529272A5 publication Critical patent/JP2012529272A5/ja
Pending legal-status Critical Current

Links

JP2012514307A 2009-06-11 2010-06-11 Gdnfおよびbdnfを中枢神経系へ送達するための融合タンパク質 Pending JP2012529272A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18624609P 2009-06-11 2009-06-11
US61/186,246 2009-06-11
PCT/CA2010/000889 WO2010142035A1 (en) 2009-06-11 2010-06-11 Fusion proteins for delivery of gdnf and bdnf to the central nervous system

Publications (2)

Publication Number Publication Date
JP2012529272A JP2012529272A (ja) 2012-11-22
JP2012529272A5 true JP2012529272A5 (enExample) 2013-07-25

Family

ID=43308346

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012514307A Pending JP2012529272A (ja) 2009-06-11 2010-06-11 Gdnfおよびbdnfを中枢神経系へ送達するための融合タンパク質

Country Status (9)

Country Link
US (1) US20120196803A1 (enExample)
EP (1) EP2440581A4 (enExample)
JP (1) JP2012529272A (enExample)
CN (2) CN103819564A (enExample)
AU (1) AU2010258052A1 (enExample)
BR (1) BRPI1012971A2 (enExample)
CA (1) CA2764777A1 (enExample)
MX (1) MX2011013258A (enExample)
WO (1) WO2010142035A1 (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE512674T1 (de) 2003-01-06 2011-07-15 Angiochem Inc Angiopep-1, verwandte verbindungen, und deren verwnedungen
PL2233156T3 (pl) 2005-07-15 2013-09-30 Angiochem Inc Zastosowanie polipeptydów aprotyninowych jako nośników w koniugatach farmaceutycznych
JP2010506860A (ja) 2006-10-19 2010-03-04 アンジオケム,インコーポレーテッド P−糖タンパク質機能を刺激するための化合物およびその使用
US9365634B2 (en) 2007-05-29 2016-06-14 Angiochem Inc. Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
WO2010043047A1 (en) 2008-10-15 2010-04-22 Angiochem Inc. Conjugates of glp-1 agonists and uses thereof
WO2010063122A1 (en) 2008-12-05 2010-06-10 Angiochem Inc. Conjugates of neurotensin or neurotensin analogs and uses thereof
EP2373789A4 (en) 2008-12-17 2012-08-29 Angiochem Inc MEMBRANTYP-1 MATRIX METALLOPROTEINASE INHIBITORS AND THEIR USE
RU2011146654A (ru) 2009-04-20 2013-05-27 Ангиокем Инк. Способы лечения рака яичников с применением конъюгированного средства
WO2011000095A1 (en) 2009-07-02 2011-01-06 Angiochem Inc. Multimeric peptide conjugates and uses thereof
WO2011153642A1 (en) * 2010-06-10 2011-12-15 Angiochem Inc. Leptin and leptin analog conjugates and fusion proteins and uses thereof
EP2588490B1 (en) * 2010-07-02 2017-02-22 Angiochem Inc. Short and d-amino acid-containing polypeptides for therapeutic conjugates and uses thereof
CN104781276A (zh) 2012-08-14 2015-07-15 安吉奥开米公司 肽-树枝状聚合物结合物及其用途
JP6234331B2 (ja) * 2014-06-13 2017-11-22 森永乳業株式会社 統合失調症治療剤
EP3307326B9 (en) 2015-06-15 2021-02-24 Angiochem Inc. Methods for the treatment of leptomeningeal carcinomatosis
EP3454886A1 (en) 2016-05-13 2019-03-20 Instituto de Medicina Molecular Methods of treating diseases associated with ilc3 cells
US11912750B2 (en) * 2016-11-10 2024-02-27 Keros Therapeutics, Inc. GDNF fusion polypeptides and methods of use thereof
CN107141354A (zh) * 2017-05-05 2017-09-08 李斯文 一种融合蛋白及光敏剂复合物及其制备方法和应用
KR20210012966A (ko) * 2019-07-24 2021-02-03 주식회사 에스엘바이젠 불사화된 줄기세포주의 제조 방법 및 이의 용도
EP4347645A1 (en) 2021-06-03 2024-04-10 Fundação D. Anna de Sommer Champalimaud e Dr. Carlos Montez Champalimaud Foundation Neuro-mesenchyme units control ilc2 and obesity via a brain-adipose circuit
CN116270429B (zh) * 2023-02-17 2025-06-10 山东省药学科学院 一种鼻黏膜给药的抗抑郁制剂及其制备方法和应用
CN120077136A (zh) * 2023-09-28 2025-05-30 广州必贝特医药股份有限公司 抑制淀粉样前体蛋白(APP)基因表达的siRNA、药物及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090016959A1 (en) * 2005-02-18 2009-01-15 Richard Beliveau Delivery of antibodies to the central nervous system
MX2007010113A (es) * 2005-02-18 2007-12-07 Angiochem Inc Polipeptidos de aprotinina para transportar un compuesto a traves de la barrera hematoencefalica.
US8053569B2 (en) * 2005-10-07 2011-11-08 Armagen Technologies, Inc. Nucleic acids encoding and methods of producing fusion proteins
CA2688344C (en) * 2007-05-29 2019-09-03 Angiochem, Inc. Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
WO2009039188A1 (en) * 2007-09-17 2009-03-26 Ludwig Institute For Cancer Research Ltd Peptides and methods for the treatment of gliomas and other cancers
WO2009070597A2 (en) * 2007-11-26 2009-06-04 Armagen Technologies, Inc. Fusion proteins for delivery of gdnf to the cns

Similar Documents

Publication Publication Date Title
JP2010534486A5 (enExample)
ES2393373T3 (es) Método para la producción de factor-I de crecimiento similar a la insulina
JP2023181445A5 (enExample)
JP2008507298A5 (enExample)
TW200833840A (en) Toxin peptide therapeutic agents
RU2016101711A (ru) Высокостабильный т-клеточный рецептор и способ его получения и применения
JP2019535267A5 (enExample)
JP2013523718A5 (enExample)
JP2005507637A5 (enExample)
CN103998458A (zh) 具有中央疏水域的细胞穿透肽
NO330538B1 (no) Anvendelse av hydrofob ladningsinduksjonskromatografi for fremstilling av renset IL-18-bindende protein samt fremgangsmate for fremstilling av renset IL -18-bindende protein
JP2013507930A5 (enExample)
JP2012525844A5 (enExample)
JP2012176978A5 (enExample)
JP2014524908A5 (enExample)
JP2013526864A5 (enExample)
CN101588820A (zh) α-乳清蛋白组合物
JP2010524958A5 (enExample)
JP2014513941A5 (enExample)
JPH10182700A (ja) 高圧液体クロマトグラフィーによるインシュリンの単離方法
JP2016525545A5 (enExample)
JP2014510101A5 (enExample)
JP2025506173A5 (enExample)
JP2024012470A5 (enExample)
JP2009507503A5 (enExample)